CRISPR-based systems for sensitive and rapid on-site COVID-19 diagnostics.

Area of Science:

• Molecular Biology
• Biotechnology
• Infectious Disease Diagnostics

Background:

• The COVID-19 pandemic highlighted the need for accessible diagnostic tools.
• Current methods like RT-PCR and antigen tests have limitations in sensitivity, specificity, and accessibility.

Purpose of the Study:

• To evaluate CRISPR-Cas systems for sensitive and specific on-site COVID-19 diagnosis.
• To discuss the potential and challenges of CRISPR-Cas diagnostics for resource-limited areas.

Main Methods:

• Review of major CRISPR-Cas systems and their mechanisms.
• Evaluation of CRISPR-Cas systems' compatibility with isothermal amplification and dipstick readout.
• Assessment of on-site diagnostic capabilities.

Main Results:

• CRISPR-Cas systems show promise for sensitive and specific on-site testing.
• Isothermal amplification and dipstick readout enable point-of-care applications.
• Current CRISPR-Cas systems require further optimization for clinical adoption.

Conclusions:

• CRISPR-Cas systems represent a viable alternative for rapid, on-site COVID-19 detection.
• Enhancing sensitivity and simplifying workflows are key for clinical implementation.
• Future research should focus on optimizing CRISPR-Cas diagnostic platforms for global health applications.